Carcinoembryonic antigen (CEA) represents an attractive target in several cancers as it is highly expressed in breast cancer (BC) [9], medullary thyroid cancer (MTC) [10] and colorectal cancer [11]. This evidence concerns the gene CEACAM5 and breast cancer.